Gastric neoplasms
Clinical trials for Gastric neoplasms explained in plain language.
Never miss a new study
Get alerted when new Gastric neoplasms trials appear
Sign up with your email to follow new studies for Gastric neoplasms, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can adding immunotherapy to standard cancer care be safe for indian patients?
Disease control Not yet recruitingThis trial tests whether pembrolizumab, an immunotherapy drug, is safe when combined with chemotherapy or chemoradiotherapy for people in India with advanced gastric or gastroesophageal junction cancer, advanced biliary tract cancer, or high-risk locally advanced cervical cancer.…
Matched conditions: GASTRIC NEOPLASMS
Phase 4 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug targets hard-to-treat cancers in early trial
Disease control Not yet recruitingThis study tests a drug called Trastuzumab Rezetecan in 15 adults with advanced solid tumors that have the HER2 protein. The goal is to see if the drug can shrink tumors. Participants get the drug by IV every 3 weeks. This is for people whose cancer has worsened after other treat…
Matched conditions: GASTRIC NEOPLASMS
Phase 2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could a simple drug combo speed up stomach ulcer healing after cancer surgery?
Disease control Not yet recruitingThis study looks at whether adding sucralfate (a protective coating agent) to standard esomeprazole (a stomach acid reducer) helps heal artificial ulcers created during endoscopic surgery for early stomach cancer or precancerous growths. About 120 adults will be randomly assigned…
Matched conditions: GASTRIC NEOPLASMS
Phase 4 • Sponsor: LanZhou University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC